These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 21489803)
21. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors. Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083 [No Abstract] [Full Text] [Related]
23. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)". Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807 [No Abstract] [Full Text] [Related]
24. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor. Gong J; Xu W Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and Biological Evaluation of Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617 [TBL] [Abstract][Full Text] [Related]
26. Structural basis for a class of nanomolar influenza A neuraminidase inhibitors. Kerry PS; Mohan S; Russell RJ; Bance N; Niikura M; Pinto BM Sci Rep; 2013 Oct; 3():2871. PubMed ID: 24129600 [TBL] [Abstract][Full Text] [Related]
27. Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases. Carbain B; Martin SR; Collins PJ; Hitchcock PB; Streicher H Org Biomol Chem; 2009 Jun; 7(12):2570-5. PubMed ID: 19503932 [TBL] [Abstract][Full Text] [Related]
28. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
29. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. Abed Y; Nehmé B; Baz M; Boivin G Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A. Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183 [TBL] [Abstract][Full Text] [Related]
31. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors. Mooney CA; Johnson SA; 't Hart P; Quarles van Ufford L; de Haan CA; Moret EE; Martin NI J Med Chem; 2014 Apr; 57(7):3154-60. PubMed ID: 24649802 [TBL] [Abstract][Full Text] [Related]
32. Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. Wen WH; Wang SY; Tsai KC; Cheng YS; Yang AS; Fang JM; Wong CH Bioorg Med Chem; 2010 Jun; 18(11):4074-84. PubMed ID: 20452227 [TBL] [Abstract][Full Text] [Related]
33. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors. Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342 [TBL] [Abstract][Full Text] [Related]
34. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors. Hong BT; Chen CL; Fang JM; Tsai KC; Wang SY; Huang WI; Cheng YE; Wong CH Bioorg Med Chem; 2014 Dec; 22(23):6647-6654. PubMed ID: 25456388 [TBL] [Abstract][Full Text] [Related]
35. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase. Kar P; Knecht V J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951 [TBL] [Abstract][Full Text] [Related]
36. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus. Park JW; Jo WH Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors. Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719 [TBL] [Abstract][Full Text] [Related]
38. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Dao TT; Nguyen PH; Lee HS; Kim E; Park J; Lim SI; Oh WK Bioorg Med Chem Lett; 2011 Jan; 21(1):294-8. PubMed ID: 21123068 [TBL] [Abstract][Full Text] [Related]
39. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity. Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836 [TBL] [Abstract][Full Text] [Related]
40. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies. Ye J; Yang X; Xu M; Chan PK; Ma C Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]